Supplementary Material 1 from Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors Ryan B. Corcoran , Khanh T. Do , Jeong E. Kim , James M. Cleary , Aparna R. Parikh , Oladapo O. Yeku , Niya Xiong , Colin D. Weekes , Jennifer Veneris , Leanne G. Ahronian , Gianluca Mauri , Jun Tian , Bryanna L. Norden , Alexa G. Michel , Emily E. Van Seventer , Giulia Siravegna , Kyle Camphausen , Gary Chi , Isobel J. Fetter , Joan S. Brugge , Helen Chen , Naoko Takebe , Richard T. Penson , Dejan Juric , Keith T. Flaherty , Ryan J. Sullivan , Jeffrey W. Clark , Rebecca S. Heist , Ursula A. Matulonis , Joyce F. Liu , Geoffrey I. Shapiro crossref(2024)
摘要
Supplementary Table S1, Supplementary Table S2, Supplementary Figure S1
更多 查看译文
AI 理解论文
溯源树
样例